Federal Register / Vol. 65, No. 231 / Thursday, November 30, 2000 / Notices 71327

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of meetings of the

National Advisory Research Resources

Council.

The meetings will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Research Resources Council, Executive

Subcommittee.

Date: January 18, 2001.

Open: 8 a.m. to 9 a.m.

Agenda: To discuss policy issues.

Place: National Center for Research

Resources, National Institutes of Health,

Conference Room 3B13, Building 31,

Bethesda, MD 20892.

Contact Person: Louise E. Ramm, PhD,

Deputy Director, National Center for

Research Resources, National Institutes of

Health, Building 31, Room 3B11, Bethesda,

MD 20892, 301–496–6023.

Name of Committee: National Advisory

Research Resources Council.

Date: January 18, 2001.

Open: 9:15 a.m. to 1:30 p.m.

Agenda: Report of Center Director and

other issues.

Place: 9000 Rockville Pike, Building 31,

Conference Room 10, Bethesda, MD 20892.

Closed: 1:30 p.m. to 3:30 p.m

Agenda: To review and evaluate grant

applications.

Place: 9000 Rockville Pike, Building 31,

Conference Room 10, Bethesda, MD 20892.

Open: 3:30 p.m. to Adjournment.

Agenda: Issues related to Council business.

Place: 9000 Rockville Pike, Building 31,

Conference Room 10, Bethesda, MD 20892.

Contact Person: Louise E. Ramm, PhD,

Deputy Director, National Center for

Research Resources, National Institutes of

Health, Building 31, Room 3B11, Bethesda,

MD 20892, 301–496–6023.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: November 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30462 Filed 11–29–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclose of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB–1(J2),

Date: December 18–20, 2000.

Time: 7:00 p.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Marriott-Baltimore Inner Harbor,

110 South Eutaw Street, Baltimore, MD

21201.

Contact Person: Carolyn Miles, PhD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Room 641, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892, (301) 594–7791.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB–2(J2).

Date: December 20, 2000.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: 2 Democracy Plaza, 6707 Democracy

Boulevard, RM 643, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Shan S. Wong, PhD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Room 643, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892, (301) 594–7797.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hermatology Research, National

Institutes of Health, HHS)

Dated: November 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30461 Filed 11–29–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Office of the Director; Recombinant

DNA Advisory Committee Meeting;

Safety Symposium on Gene Transfer

Research

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Recombinant DNA Advisory Committee

(RAC) and a Safety Symposium on Gene

Transfer Research.

The RAC meeting will be held from 8

a.m. to 5 p.m. on December 13 and 15,

2000 at the National Institutes of Health

(NIH), Building 31, C Wing, Conference

Room 10, 9000 Rockville Pike,

Bethesda, MD 20892. The Committee

will review changes to the process for

submission and review of gene transfer

research protocols; selected human gene

transfer protocols; NIH policy on serious

adverse event reporting; data

management activities related to human

gene transfer clinical trials; and other

matters to be considered by the

Committee.

The Safety Symposium on Gene

Transfer Research will be held from 8

a.m. to 5 p.m. on December 14, 2000 at

the NIH Natcher Auditorium, 9000

Rockville Pike, Bethesda, MD 20892.

The symposium will explore safety

considerations in gene transfer clinical

research in cardiovascular diseases.

Both meetings are open to the public

with attendance limited to space

available. Draft meeting agendas and

other information will be posted at the

Office of Biotechnology Activities’

website: http://www.nih.gov/od/oba.

Individuals who wish to provide

public comments or who plan to attend

the meeting and need special assistance,

such as sign language interpretation or

other reasonable accommodations,

should notify Kelly Fennington,

Program Analyst, Office of